Emerald Clinical
Biotechnology ResearchCentral Region, Singapore201-500 Employees
Emerald Clinical is a global contract research organization that provides end-to-end clinical trial services across Phases I through IV and real-world studies. Headquartered in Singapore, Central Region, the company operates with more than 800 professionals and maintains a collaborative network spanning over 40 countries and 70 locations. It serves a broad client base that includes biotech firms and 15 of the world's top 20 pharmaceutical companies, leveraging scientific and operational expertise to advance therapies. The firm's core focus areas include renal, oncology, autoimmune, ophthalmology, cardiometabolic, and early-phase development, supporting trials across diverse therapy areas. In December 2025, Emerald Clinical Trials appointed Luke Gill as Vice President, Global Head of Oncology, Medical & Scientific Affairs. In March 2026, the company received the Asia Pacific Biopharma Excellence Award for Outstanding Patient Recruitment & Engagement.